PreveCeutical Medical
(OTC) PRVCF
PreveCeutical Medical Financials at a Glance
Market Cap
$9.66M
Revenue (TTM)
$0.00
Net Income (TTM)
$1.63M
EPS (TTM)
$-0.00
P/E Ratio
-7.84
Dividend
$0.00
Beta (Volatility)
0.05 (Low)
Dividend
$0.00
Beta (Volatility)
0.05 (Low)
Price
$0.02
Volume
50,204
Open
$0.02
Price
$0.02
Volume
50,204
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.00 - $0.04
Dividend
$0.00
Beta (Volatility)
0.05 (Low)
Price
$0.02
Volume
50,204
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.00 - $0.04
PRVCF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PreveCeutical Medical
Industry
Pharmaceuticals
Sector
Health CareCEO
Stephen van Deventer
Website
www.preveceutical.comHeadquarters
Vancouver, BC V6B 0R6, CA
PRVCF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
59%
Return on Assets
-1%
Earnings Yield
-12.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.66M
Shares Outstanding
586.81M
Volume
50.20K
Avg. Volume
43.90K
Financials (TTM)
Gross Profit
$14.41K
Operating Income
$3.36M
EBITDA
$3.35M
Operating Cash Flow
$1.72M
Capital Expenditure
$2.96K
Free Cash Flow
$1.72M
Cash & ST Invst.
$10.23K
Total Debt
$4.67M
PreveCeutical Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$3.63K
N/A
Gross Margin
0.00%
N/A
Market Cap
$9.66M
N/A
Market Cap/Employee
$1.38M
N/A
Employees
7
N/A
Net Income
$1.21M
+601.9%
EBITDA
$717.65K
-356.6%
Quarterly Fundamentals
Net Cash
$4.66M
-5.9%
Accounts Receivable
$1.01M
+3607.5%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$4.67M
+6.3%
Return on Assets
-1.12%
N/A
Return on Invested Capital
59.39%
N/A
Free Cash Flow
$533.95K
-701.4%
Operating Cash Flow
$533.95K
-710.1%